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1. Introduction 
We have shown that washed cell suspensions of the 
three main morphological forms of Trypanosoma 
cruzi, the causative agent for Chagas’ disease, in- 
corporated radiolabelled bicarbonate into nucleic acid 
pyrimidines, suggesting that all forms can biosyn- 
thesise these compounds de novo [l] . This conclu- 
sion is in agreement with what is known about py- 
rimidine biosythesis generally in parasitic protozoa 
[2,3], but differs from that drawn for T. cruzi in 
[4,5]. Here we confirm our conclusion by demonstra- 
tion that all six enzymes of the pyrimidine bio- 
sythetic pathway are present in the three main forms 
of T. cruzi. We also show that the last three enzymes 
of the pathway have an unusual intracellular distribu- 
tion. 
2. Materials and methods 
The preparation of culture epimastigote, blood 
trypomastigote and intracellular amastigote forms 
of the Sonya strain of i? cruzi has been described 
[6,7]. To prepare enzyme extracts, organisms 
( IO9 cells/ml assay buffer) were usually broken by 
3 cycles of freezing and thawing. However, for 
ammonium-dependent and glutamine-dependent car- 
bamoyl-phosphate synthetases (CPSase I and CPSase 
II, respectively) parasites suspended in water were 
Abbreviations: ACTase, aspartate carbamoyltransferase 
(EC 2.1.3.2); CPSase I, carbamoyl-phosphate synthetase 
(ammonia) (EC 6.3.4.16); CPSase 11, carbamoyl-phosphate 
synthetase (L-glutamine) (EC 6.3.5.5); DHOasc, dihydro- 
orotase (EC 3.5.2.3); DHOHase, dihydroorotate hydroxylase 
(EC unclassified); ODCase, orotidine-5’-phosphate 
decarboxylase (EC 4.1.1.23) and OPRTase, orotate phos- 
phoribosyltransferase (EC 2.4.2.10) 
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disrupted in a tight-fitting glass homogeniser (water 
lysis). All extracts were dialysed before use. 
Homogenates for cell fractionation were prepared 
either by grinding with silicon carbide, or by water 
lysis. The extracts were centrifuged at 2500 X gmax 
for 15 mm to remove whole cells and other large debris, 
then centrifuged at 200 000 X g,,, for 20 min to yield 
particulate and supernatant fractions. All enzyme activ- 
ities were measured in the physiological direction. As- 
says for CPSase I and II [8], aspartate carbamoyltrans- 
ferase (ACTase) [9] and dihydroorotate hydroxylase 
(ACTase) [9] and dihydroorotate hydroxylase 
(DHOHase) [lo] were based on published methods. 
The assay of dihydro-orotase (DHOase) measured the 
production of radioactive dihydroorotate from 
[r4C]carbamoyl-Laspartate. Orotate phosphoribosyl- 
transferase (OPRTase) was assayed by measuring the 
production of radioactive OMP and UMP from 
[5-3H]orotic acid. Orotidine-5’-phosphate decar- 
boxylase (ODCase) activity was assayed by estimating 
the production of radioactive UMP, uracil and 
uridine (products of UMP metabolism) from radio- 
active OMP. Separation of radioactive metabolites 
was carried out on PEl-cellulose thin layer chromato- 
grams by the method in [ 111. Chromatograms were 
cut up and estimated for radioactivity. Full details 
of all these procedures will be given subsequently. 
Protein was assayed by the Lowry method [ 121. 
3. Results 
Table 1 shows the specific activities in broken cell 
preparations of epimastigote, amastigote, and trypo- 
mastigote forms of T. cruzi for the six enzymes 
required for pyrimidine biosynthesis de novo. These 
activities refer to unfractionated homogenates and 
were all measured at optimal pH in the physiological 
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Table 1 
Specific activities of the enzymes of the pyrimrdine biosynthetic pathway in T. cmzi 
_ 
Morphological form 
PH 
Enzyme optimum Epimastigote (28°C) Amastigote (37°C) Trypomastigote (37°C) 
CPSase I 8.8 1.5 * 0.8 (4)a 5.2 f 1.9 (3) 2.9 f 0.4 (3) 
CPSase 11 7.1 1.0 ? 0.4 (4) 2.6 + 1.4 (3) 1.6 i- 0.7 (3) 
ACTase 8.5 15 f 2 (3) 22 +3 (2) 31 +1 (2) 
DHOase 6.5 0.09 * 0.01 (4) 0.16 ? 0.05 (3) 0.25 + 0.03 (3) 
DHOHase 889.5 0.38 f 0.06 (2) 0.26 f 0.03 (2) 0.37 f 0.04 (2) 
OPRTase 7.4 0.14 f 0.02 (2) 0.07 f 0.01 (3) 0.24 f 0.09 (2) 
ODCase 8.5 0.50 f 0.14 (2) 1.6 i 0.2 (2) 1.9 f 0.4 (3) 
a nmol . min-' . mg protein-’ 
The figures represent means f SD no. determinations from separate experiments in brackets 
direction under conditions of saturating substrate 
concentrations (based on the reported Km values 
for the isofunctional enzymes in other cells, reviewed 
in [ 131). The pH optima were obtained using par- 
tially purified enzyme extracts of epimastigotes. 
The enzymes with the lowest specific activities have 
optima near to physiological pH. The activity at 
pH 7.0 of ACTase is 7.5 that of DHOHase, 0.2, that 
of ODCase, 0.25 and that of CPSase I, 0.07 nmol . 
Table 2 
Distribution of pyrimidine biosynthetic activities in 
homogenates of epimastigotes of T. cruzi 
Relative spec. act.b 
Total 
Enzyme acta Pellet Supern. 
CPSase I 0.05 0.93 1.1 
(2.6) (0.28) (2.1) 
CPSase 11 n.d. _ 
(4.2) (0.24) (2.2) 
ACTase 17 0.12 1.7 
(130) (0.34) (2.1) 
DHOase 0.35 0.09 2.2 
DHOHase 0.10 <0.15c >2.1 
OPRTase 0.12 >I.6 <0.23c 
(1.2) >I.6 <0.12c 
ODCase 0.26 1.6 0.18 
a nmol . min-* . mg protein-’ at 28°C 
b % total activity/% total protein 
c Activity not detected; the figure given represents the limit 
of reproducible detection 
n.d., Not detected 
The figures in brackets refer to fractions prepared by water 
lysis; all other results refer to fractions obtained through 
grinding with silicon carbide 
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mm-‘. mg protein-‘. The specific activities of the 
enzymes within the pathway show great variation 
(e.g., 0.1-1.5 nmol . min-l. mg protein-’ in epi- 
mastigotes). However, each enzyme shows compara- 
tively little difference in activity in the three forms 
of this organism. 
Both CPSase I and CPSase II activities were detect- 
ed in all forms of T. cruzi. N-Acetyl-L-glutamate was 
routinely added to ammonium-dependent assays. 
However, its requirement could not be demonstrated, 
possibly because the duration of dialysis was ne- 
cessarily short (10 min) due to enzyme instability. 
This may not have removed sufficient endogenous 
N-acetyl-L-glutamate to demonstrate its dependence. 
The effect of pH on CPSase I and CPSase II 
activities suggests that, under physiological condi- 
tions, glutamine is the more likely ammonium donor 
for pyrimidine biosynthesis. 
The distribution of the biosynthetic enzymes in 
pellet and supernatant fractions of homogenates of 
epimastigotes are given in table 2. The results for the 
preparation obtained by silicon carbide grinding 
show little detectable CPSase activity. The other 
enzyme activities are comparable to those obtained 
by freezing and thawing (table 1). ACTase, DHOase 
and DHOHase were found to be predominantly in the 
supernatant fraction, while OPRTase and ODCase, 
the terminal two enzymes in the pathway, were in the 
particulate fraction. This distribution has been found 
routinely by breaking the cells through freezing and 
thawing. 
Using water lysates, high CPSase I and CPSase II 
activities were found. Both were predominantly in 
the supernatant fraction, as was ACTase, while 
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OPRTase was particulate. The increase in specific 
activities of these three enzymes by this method over 
those found in table 1 was probably due to more 
cell protein being pelleted during centrifugation at 
2500 x gmax for 15 min prior to fractionation. The 
result for the CPSase I activity from silicon carbide 
grinding indicates that the enzyme is polydisperse. 
However, the total activity in this preparation 
represent such a small % of what is present that it 
suggests the result is artifactual. 
each form, but there is comparatively little differ- 
ence between each enzyme in the three forms of T. 
cruzi. Our results thus add more evidence to the 
suggestion that there is little biochemical difference 
in the pyrimidine biosynthetic pathways of epima- 
stigote, amastigote, and trypomastigote forms of 
T. cruzi [l]. 
The high specific activities of both CPSase I and 
CPSase II (table 1) and ACTase suggests that, unlike 
the pathways of many other cells, neither CPSase I 
and CPSase II nor ACTase are likely to be important 
regulatory enzymes in T. cruzi. 
4. Discussion 
All the enzyme activities necessary for the de now 
biosynthesis of UMP were detected in broken cell 
preparations of amastigote, trypomastigote, and 
epimastigote forms of T. cruzi (table 1). All were 
measured in the physiological direction and were 
sufficient to account for the majority of the 
pyrimidine requirements of the organism (-0.1 
nmol . min-’ . mg protein-‘). The relatively low 
activity for OPRTase from amastigotes (0.07 nmol. 
min-’ .mg protein-’ ) may be due to sub-optimal 
conditions of preparation. In particular the method 
of cell breakage can have major effects upon enzyme 
activity [ 141 and significant inhibition may be 
occurring due to the presence of potential inhibitors 
in the commercial 5’-phosphoribosyl 1 -pyrophos- 
phate used in the assay. 
The results in table 1 provide a feasible explana- 
tion for the incorporation of radioactive bicarbonate 
into RNA and DNA [ 11. Despite the existence of 
potential salvage pathways [ 1,4,5], it seems likely 
that in vivo blood and intracellular forms of T. cruzi 
will depend primarily on this de nova pathway as a 
source of pyrimidines. This situation is similar to that 
described for Trypunosoma equiperdum [ 151. 
In common with other known pyrimidine bio- 
synthetic pathways, CPSase II, ACTase, and DHOase 
are soluble enzymes. In contrast to other cells, 
OPRTase and ODCase are particulate enzymes, not 
only in T. cruzi (table 2) but also in Leishmania 
mexicana mexicana [ 171 and probably in T. equiper- 
dum [ 151. It is possible that this difference may be a 
characteristic of the Kinetoplastida, and may allow 
parasite-specific inhibitors to be found of the type 
described [ 151 for the pyrimidine biosynthetic 
pathway of the members of this order. Such inhibi- 
tors could be synergistic with inhibitors of DHOHase. 
In the Kinetoplastida this enzyme is soluble (table 2 
and [lo]) and requires oxygen for activity, but is 
not sensitive to inhibition by CN- (10 mM) or 
antimycin A (100 /-@ml). In contrast, in mamma- 
lian cells the isofunctional enzyme is a dehydrogenase 
which is particulate, mitochondrial and intimately 
connected to the respiratory chain to which it passes 
electrons directly, probably at the ubiquinone level 
[lOI. 
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